{"id":"W2990546292","doi":"10.23736/s1121-421x.19.02625-4","title":"Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Minerva Gastroenterologica e Dietologica","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Vedolizumab; Medicine; Therapeutic drug monitoring; Inflammatory bowel disease; Intensive care medicine; Drug; Clinical trial; Clinical Practice; Disease; Internal medicine; Pharmacology; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003177323,0.0003641123,0.001044761,0.001582191,0.0001487654,0.001007327,0.0004862172,0.0007152624,0.001090256],"category_scores_gemma":[0.005155863,0.0001826177,0.0007286387,0.001378745,0.0004961151,0.0007750372,0.000505216,0.0009574298,0.0003029471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005277399,"about_ca_system_score_gemma":0.0006401931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000749968,"about_ca_topic_score_gemma":0.001086532,"domain_scores_codex":[0.9977261,0.001111734,0.000326273,0.0002358841,0.000549981,0.00005006901],"domain_scores_gemma":[0.9975503,0.001351207,0.0006958661,0.00006429818,0.000286649,0.00005173396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009124165,0.00009294123,0.003538054,0.01503455,0.0006926916,0.0003015567,0.0001079905,0.0007866137,0.005639303,0.002460682,0.004684432,0.9657488],"study_design_scores_gemma":[0.001062598,0.004030642,0.07128857,0.0230196,0.004076523,0.01224317,0.0003796107,0.005818217,0.02630819,0.01216032,0.8393806,0.0002321149],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005581297,0.9882364,0.002775612,0.0008149599,0.0001775512,0.00002973109,0.00007242036,0.00003741229,0.002274686],"genre_scores_gemma":[0.130421,0.8559002,0.009875882,0.001572045,0.0006587208,0.0001104341,0.0001977976,0.0000171579,0.001246663],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003177323,"threshold_uncertainty_score":0.0168035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04394553222243223,"score_gpt":0.3034427132446421,"score_spread":0.2594971810222099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}